Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin)

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 405-410

  Arnett, Frank C ^a   Fritzler, Marvin J ^a   Ahn, Chul ^a   Holian, Andrij ^a  

^a NONE

Author keywords

Autoantibodies; Connective tissue diseases; Mercury; Scleroderma; Systemic sclerosis; U3 RNP (fibrillarin)

Indexed keywords

AUTOANTIBODY; FIBRILLARIN; FIBRILLARIN ANTIBODY; MERCURIC CHLORIDE; MERCURY; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; ATOMIC ABSORPTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MERCURIALISM; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; URINE LEVEL;

ANIMALS; AUTOANTIBODIES; CHROMOSOMAL PROTEINS, NON-HISTONE; HUMANS; MERCURY; MICE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 0033960851     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arnett FC. HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol 1995;12:107-28.
2. Tan EM. Autoantibodies in pathology and cell biology. Cell 1991;67:841-2.
3. Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997;185:71-9.
4. Rosen A, Casciola-Rosen L, Wigley F. Role of metal catalyzed oxidation reactions in the early pathogenesis of scleroderma. Curr Opin Rheumatol 1997;9:538-43.
5. Arnett FC, Reveille JD, Goldstein R, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996;39:1151-60.
6. Reuter R, Tessars G, Vohr HW, Gleichmann E, Luhrmann R. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci USA 1989;86:237-41.
7. Hultman P, Bell LJ, Enestrom S, Pollard KM. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol 1992;65:98-109.
8. Pollard KM, Lee DK, Casiano CA, Bluther M, Johnston MM, Tan EM. The autoimmunity inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 1997;158:3521-8.
9. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
10. Littlejohn D, Fell GS, Ottaway JM. Modified determination of total and inorganic mercury in urine by cold vapor atomic absorption spectrometry. Clin Chem 1976;22:1719-23.
11. Johnson and Johnson Clinical Diagnostics Inc. 1995;MP2-49.
12. Silman AJ, Hochberg MC. Occupational and environmental influences on scleroderma. Rheum Dis Clin N Am 1996;22:737-49.
13. McHugh NJ, Whyte J, Harvey G, Haustein UF. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. Arthritis Rheum 1994;37:1198-205.
14. Kulig K. A tragic reminder about organic mercury [editorial]. N Engl J Med 1998;338:1692-4.
15. Junghans RP. A review of the toxicity of methylmercury compounds with application to occupational exposures associated with laboratory uses. Environ Res 1983;31:1-31.